{"entity":{"type":"insider","cik":"0001311210","url":"/insider/0001311210","json_url":"/insider/0001311210.json","name":"Machado Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":117,"n_filings":57,"first":"2007-03-20","last":"2021-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Machado Patrick","source":"filing","n_filings":17,"first_seen":"2016-09-16","last_seen":"2021-03-24"},{"name":"Machado Clarence Patrick","source":"filing","n_filings":40,"first_seen":"2007-03-20","last_seen":"2016-06-28"}],"transactions":[{"id":4529115,"accession":"0001209191-21-022933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-022933","line_url":"/filing/0001209191-21-022933#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.9196,"price_display":"9.92","price_state":"stated","total_value":99196.0,"total_display":"99,196.00","total_whole":"99,196","shares_owned_after":88182.0,"shares_owned_after_display":"88,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-24","scope":"insider"},{"id":4923865,"accession":"0001209191-21-004143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-004143","line_url":"/filing/0001209191-21-004143#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":11.5174,"price_display":"11.52","price_state":"stated","total_value":115174.0,"total_display":"115,174.00","total_whole":"115,174","shares_owned_after":78182.0,"shares_owned_after_display":"78,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":8417159,"accession":"0001104659-19-036422","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-036422","line_url":"/filing/0001104659-19-036422#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4957.0,"shares_display":"4,957","price_per_share":8.1693,"price_display":"8.17","price_state":"stated","total_value":40495.2201,"total_display":"40,495.22","total_whole":"40,495","shares_owned_after":22860013.0,"shares_owned_after_display":"22,860,013","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-19","scope":"insider"},{"id":8417156,"accession":"0001104659-19-036422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-036422","line_url":"/filing/0001104659-19-036422#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6706.0,"shares_display":"6,706","price_per_share":8.2107,"price_display":"8.21","price_state":"stated","total_value":55060.9542,"total_display":"55,060.95","total_whole":"55,061","shares_owned_after":22855056.0,"shares_owned_after_display":"22,855,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider"},{"id":8417151,"accession":"0001104659-19-036422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-036422","line_url":"/filing/0001104659-19-036422#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6541.0,"shares_display":"6,541","price_per_share":8.5346,"price_display":"8.53","price_state":"stated","total_value":55824.8186,"total_display":"55,824.82","total_whole":"55,825","shares_owned_after":22848350.0,"shares_owned_after_display":"22,848,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":7969888,"accession":"0001104659-19-035731","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-035731","line_url":"/filing/0001104659-19-035731#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7144.0,"shares_display":"7,144","price_per_share":7.9107,"price_display":"7.91","price_state":"stated","total_value":56514.0408,"total_display":"56,514.04","total_whole":"56,514","shares_owned_after":22841809.0,"shares_owned_after_display":"22,841,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-14","scope":"insider"},{"id":7969886,"accession":"0001104659-19-035731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-035731","line_url":"/filing/0001104659-19-035731#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7367.0,"shares_display":"7,367","price_per_share":7.9466,"price_display":"7.95","price_state":"stated","total_value":58542.6022,"total_display":"58,542.60","total_whole":"58,543","shares_owned_after":22834665.0,"shares_owned_after_display":"22,834,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-14","scope":"insider"},{"id":7969882,"accession":"0001104659-19-035731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-035731","line_url":"/filing/0001104659-19-035731#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":8.2992,"price_display":"8.30","price_state":"stated","total_value":62244.0,"total_display":"62,244.00","total_whole":"62,244","shares_owned_after":22827298.0,"shares_owned_after_display":"22,827,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-14","scope":"insider"},{"id":8201008,"accession":"0001104659-19-034834","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-034834","line_url":"/filing/0001104659-19-034834#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7189.0,"shares_display":"7,189","price_per_share":8.5817,"price_display":"8.58","price_state":"stated","total_value":61693.8413,"total_display":"61,693.84","total_whole":"61,694","shares_owned_after":22819798.0,"shares_owned_after_display":"22,819,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-11","scope":"insider"},{"id":8201004,"accession":"0001104659-19-034834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-034834","line_url":"/filing/0001104659-19-034834#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":8.3459,"price_display":"8.35","price_state":"stated","total_value":62594.25,"total_display":"62,594.25","total_whole":"62,594","shares_owned_after":22812609.0,"shares_owned_after_display":"22,812,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-11","scope":"insider"},{"id":8201001,"accession":"0001104659-19-034834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034834","line_url":"/filing/0001104659-19-034834#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6649.0,"shares_display":"6,649","price_per_share":7.965,"price_display":"7.96","price_state":"stated","total_value":52959.285,"total_display":"52,959.28","total_whole":"52,959","shares_owned_after":22805109.0,"shares_owned_after_display":"22,805,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-07","filed_date":"2019-06-11","scope":"insider"},{"id":8200993,"accession":"0001104659-19-034349","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-034349","line_url":"/filing/0001104659-19-034349#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7082.0,"shares_display":"7,082","price_per_share":7.9951,"price_display":"8.00","price_state":"stated","total_value":56621.2982,"total_display":"56,621.30","total_whole":"56,621","shares_owned_after":22798460.0,"shares_owned_after_display":"22,798,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-06","scope":"insider"},{"id":8200990,"accession":"0001104659-19-034349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-034349","line_url":"/filing/0001104659-19-034349#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6540.0,"shares_display":"6,540","price_per_share":8.015,"price_display":"8.02","price_state":"stated","total_value":52418.1,"total_display":"52,418.10","total_whole":"52,418","shares_owned_after":22791378.0,"shares_owned_after_display":"22,791,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-06","scope":"insider"},{"id":8200986,"accession":"0001104659-19-034349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034349","line_url":"/filing/0001104659-19-034349#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":7.5881,"price_display":"7.59","price_state":"stated","total_value":56910.75,"total_display":"56,910.75","total_whole":"56,911","shares_owned_after":22784838.0,"shares_owned_after_display":"22,784,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":7777435,"accession":"0001104659-19-034355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034355","line_url":"/filing/0001104659-19-034355#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, $0.000017727 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2424242.0,"shares_display":"2,424,242","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":19999996.5,"total_display":"19,999,996.50","total_whole":"19,999,997","shares_owned_after":40765599.0,"shares_owned_after_display":"40,765,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":8200983,"accession":"0001104659-19-033505","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-033505","line_url":"/filing/0001104659-19-033505#line-4","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5424.0,"shares_display":"5,424","price_per_share":7.7092,"price_display":"7.71","price_state":"stated","total_value":41814.7008,"total_display":"41,814.70","total_whole":"41,815","shares_owned_after":22777338.0,"shares_owned_after_display":"22,777,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-03","scope":"insider"},{"id":8200979,"accession":"0001104659-19-033505","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-033505","line_url":"/filing/0001104659-19-033505#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5071.0,"shares_display":"5,071","price_per_share":7.6991,"price_display":"7.70","price_state":"stated","total_value":39042.1361,"total_display":"39,042.14","total_whole":"39,042","shares_owned_after":22771914.0,"shares_owned_after_display":"22,771,914","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":8200976,"accession":"0001104659-19-033505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-033505","line_url":"/filing/0001104659-19-033505","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7251.0,"shares_display":"7,251","price_per_share":8.011242945800578,"price_display":"8.01","price_state":"stated","total_value":58089.5226,"total_display":"58,089.52","total_whole":"58,090","shares_owned_after":22766543.0,"shares_owned_after_display":"22,766,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider","n_lines":2},{"id":8547970,"accession":"0001104659-19-032476","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-032476","line_url":"/filing/0001104659-19-032476#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6882.0,"shares_display":"6,882","price_per_share":7.5535,"price_display":"7.55","price_state":"stated","total_value":51983.187,"total_display":"51,983.19","total_whole":"51,983","shares_owned_after":22759592.0,"shares_owned_after_display":"22,759,592","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-29","scope":"insider"},{"id":8547967,"accession":"0001104659-19-032476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-032476","line_url":"/filing/0001104659-19-032476#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3807.0,"shares_display":"3,807","price_per_share":7.6818,"price_display":"7.68","price_state":"stated","total_value":29244.6126,"total_display":"29,244.61","total_whole":"29,245","shares_owned_after":22752710.0,"shares_owned_after_display":"22,752,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-29","scope":"insider"},{"id":8547964,"accession":"0001104659-19-032476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-032476","line_url":"/filing/0001104659-19-032476#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3796.0,"shares_display":"3,796","price_per_share":7.7011,"price_display":"7.70","price_state":"stated","total_value":29233.3756,"total_display":"29,233.38","total_whole":"29,233","shares_owned_after":22748903.0,"shares_owned_after_display":"22,748,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-24","filed_date":"2019-05-29","scope":"insider"},{"id":8026506,"accession":"0001104659-19-031532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-031532","line_url":"/filing/0001104659-19-031532#line-3","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4802.0,"shares_display":"4,802","price_per_share":7.7576,"price_display":"7.76","price_state":"stated","total_value":37251.9952,"total_display":"37,252.00","total_whole":"37,252","shares_owned_after":22745107.0,"shares_owned_after_display":"22,745,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-23","filed_date":"2019-05-23","scope":"insider"},{"id":8026505,"accession":"0001104659-19-031532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-031532","line_url":"/filing/0001104659-19-031532#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5033.0,"shares_display":"5,033","price_per_share":8.0584,"price_display":"8.06","price_state":"stated","total_value":40557.9272,"total_display":"40,557.93","total_whole":"40,558","shares_owned_after":22740305.0,"shares_owned_after_display":"22,740,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-23","scope":"insider"},{"id":8026504,"accession":"0001104659-19-031532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-031532","line_url":"/filing/0001104659-19-031532#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9995.0,"shares_display":"9,995","price_per_share":8.5151,"price_display":"8.52","price_state":"stated","total_value":85108.4245,"total_display":"85,108.42","total_whole":"85,108","shares_owned_after":22735272.0,"shares_owned_after_display":"22,735,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-23","scope":"insider"},{"id":8379756,"accession":"0001104659-19-030617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-030617","line_url":"/filing/0001104659-19-030617","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.0524831,"price_display":"8.05","price_state":"stated","total_value":80524.831,"total_display":"80,524.83","total_whole":"80,525","shares_owned_after":22723562.0,"shares_owned_after_display":"22,723,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-20","scope":"insider","n_lines":2},{"id":8379750,"accession":"0001104659-19-030617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-030617","line_url":"/filing/0001104659-19-030617#line-2","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6200.0,"shares_display":"6,200","price_per_share":7.3615,"price_display":"7.36","price_state":"stated","total_value":45641.3,"total_display":"45,641.30","total_whole":"45,641","shares_owned_after":22715277.0,"shares_owned_after_display":"22,715,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-20","scope":"insider"},{"id":8379746,"accession":"0001104659-19-030617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-030617","line_url":"/filing/0001104659-19-030617#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5408.0,"shares_display":"5,408","price_per_share":6.7896,"price_display":"6.79","price_state":"stated","total_value":36718.1568,"total_display":"36,718.16","total_whole":"36,718","shares_owned_after":22709077.0,"shares_owned_after_display":"22,709,077","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-20","scope":"insider"},{"id":8093424,"accession":"0001104659-19-016043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-016043","line_url":"/filing/0001104659-19-016043#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Axovant Sciences Ltd.","issuer_ticker":"AXON","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6666667.0,"shares_display":"6,666,667","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":10000000.5,"total_display":"10,000,000.50","total_whole":"10,000,001","shares_owned_after":105952381.0,"shares_owned_after_display":"105,952,381","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":6352832,"accession":"0001104659-18-073900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-073900","line_url":"/filing/0001104659-18-073900#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Axovant Sciences Ltd.","issuer_ticker":"AXON","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000000.0,"shares_display":"10,000,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":99285714.0,"shares_owned_after_display":"99,285,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-20","scope":"insider"},{"id":6541161,"accession":"0001104659-18-060346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-060346","line_url":"/filing/0001104659-18-060346#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, $0.000037453 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2678571.0,"shares_display":"2,678,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":37499994.0,"total_display":"37,499,994.00","total_whole":"37,499,994","shares_owned_after":22703669.0,"shares_owned_after_display":"22,703,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider"},{"id":5983774,"accession":"0001104659-18-038769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-038769","line_url":"/filing/0001104659-18-038769#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Axovant Sciences Ltd.","issuer_ticker":"AXON","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14285714.0,"shares_display":"14,285,714","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":24999999.5,"total_display":"24,999,999.50","total_whole":"25,000,000","shares_owned_after":89285714.0,"shares_owned_after_display":"89,285,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider"},{"id":6183337,"accession":"0001104659-18-022435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-022435","line_url":"/filing/0001104659-18-022435#line-1","is_derivative":false,"issuer_cik":"0001311210","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001311210","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, $0.000017727 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1110015.0,"shares_display":"1,110,015","price_per_share":20.27,"price_display":"20.27","price_state":"stated","total_value":22500004.05,"total_display":"22,500,004.05","total_whole":"22,500,004","shares_owned_after":38341357.0,"shares_owned_after_display":"38,341,357","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":2534966,"accession":"0001628280-16-019607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-16-019607","line_url":"/filing/0001628280-16-019607#line-1","is_derivative":false,"issuer_cik":"0001178253","issuer_name":"SCYNEXIS INC","issuer_ticker":"SCYX","issuer_name_source":null,"issuer_url":"/issuer/0001178253","owner_cik":"0001311210","owner_name":"Machado Patrick","owner_display_name":"Machado Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.94,"price_display":"2.94","price_state":"stated","total_value":117600.0,"total_display":"117,600.00","total_whole":"117,600","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider"},{"id":2359790,"accession":"0001628280-16-017407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-16-017407","line_url":"/filing/0001628280-16-017407#line-1","is_derivative":false,"issuer_cik":"0001178253","issuer_name":"SCYNEXIS INC","issuer_ticker":"SCYX","issuer_name_source":null,"issuer_url":"/issuer/0001178253","owner_cik":"0001311210","owner_name":"Machado Clarence Patrick","owner_display_name":"Machado Clarence Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":47800.0,"total_display":"47,800.00","total_whole":"47,800","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider"},{"id":2916596,"accession":"0001209191-16-092938","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-092938","line_url":"/filing/0001209191-16-092938","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001311210","owner_name":"Machado Clarence Patrick","owner_display_name":"Machado Clarence Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":37.34082746666667,"price_display":"37.34","price_state":"stated","total_value":2800562.06,"total_display":"2,800,562.06","total_whole":"2,800,562","shares_owned_after":104135.0,"shares_owned_after_display":"104,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider","n_lines":4},{"id":8887813,"accession":"0001209191-15-087355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-087355","line_url":"/filing/0001209191-15-087355#line-1","is_derivative":false,"issuer_cik":"0001117480","issuer_name":"CHIMERIX INC","issuer_ticker":"CMRX","issuer_name_source":null,"issuer_url":"/issuer/0001117480","owner_cik":"0001311210","owner_name":"Machado Clarence Patrick","owner_display_name":"Machado Clarence Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.0846,"price_display":"7.08","price_state":"stated","total_value":70846.0,"total_display":"70,846.00","total_whole":"70,846","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-29","filed_date":"2015-12-30","scope":"insider"},{"id":8848994,"accession":"0001209191-15-072348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-072348","line_url":"/filing/0001209191-15-072348","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001311210","owner_name":"Machado Clarence Patrick","owner_display_name":"Machado Clarence Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71980.0,"shares_display":"71,980","price_per_share":42.360458460683525,"price_display":"42.36","price_state":"stated","total_value":3049105.8,"total_display":"3,049,105.80","total_whole":"3,049,106","shares_owned_after":104300.0,"shares_owned_after_display":"104,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-25","filed_date":"2015-09-28","scope":"insider","n_lines":4},{"id":8461199,"accession":"0001209191-15-051143","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-051143","line_url":"/filing/0001209191-15-051143","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001311210","owner_name":"Machado Clarence Patrick","owner_display_name":"Machado Clarence Patrick","owner_url":"/insider/0001311210","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":117.42994444444444,"price_display":"117.43","price_state":"stated","total_value":4227478.0,"total_display":"4,227,478.00","total_whole":"4,227,478","shares_owned_after":50900.0,"shares_owned_after_display":"50,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-04","filed_date":"2015-06-08","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":"2015-06-04|8461185","ledger_fault":false,"count":{"value":117,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":37,"open_market":true},{"code":"S","label":"Open-market sale","n":80,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":117},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Adverum Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Director","n_filings":2,"first_seen":"2021-01-19","last_seen":"2021-03-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001740547","name":"Urovant Sciences Ltd.","url":"/issuer/0001740547","role":"Ten percent owner","n_filings":9,"first_seen":"2018-10-03","last_seen":"2019-06-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Ten percent owner","n_filings":2,"first_seen":"2018-04-04","last_seen":"2019-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001636050","name":"Axovant Sciences Ltd.","url":"/issuer/0001636050","role":"Ten percent owner","n_filings":3,"first_seen":"2018-06-07","last_seen":"2019-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001178253","name":"SCYNEXIS INC","url":"/issuer/0001178253","role":"Director","n_filings":2,"first_seen":"2016-06-28","last_seen":"2016-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001011835","name":"MEDIVATION, INC.","url":"/issuer/0001011835","role":"Director, Officer (Chief Business Officer and CFO)","n_filings":38,"first_seen":"2007-03-20","last_seen":"2016-01-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001117480","name":"CHIMERIX INC","url":"/issuer/0001117480","role":"Director","n_filings":1,"first_seen":"2015-12-30","last_seen":"2015-12-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001311210","retrieved_at":"2026-08-25T07:41:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}